Specialty Pharmacy

One round of investigational combination treatment may be more effective than long-term treatment for multiple sclerosis.

Efficacy of tocilizumab monotherapy was maintained or improved for up to 264 weeks.

Top news of the day from across the health care landscape.

Although PrEP is highly effective, few appropriate patients with HIV currently use it.

Long-acting antiretroviral maintains significant viral load reduction and increases CD4+ T cells in HIV.

Flawed patents challenged on blockbuster HCV drugs to allow generic production.

SMAC mimetics and immune checkpoint inhibitors, together, promote tumor immunity against deadly brain cancer.

The American Diabetes Association releases an update position statement reflecting the current diabetic neuropathy landscape.

Findings suggest that human genetics trigger mutations in the HIV viral genome.

Top news of the day from across the health care landscape.

Review the new products and expanded indications approved by the FDA in January 2017.

Top news of the week in oncology and cancer drug development.

The Specialty Pharmacy Patient Choice Award was created by Zitter Health Insights and Specialty Pharmacy Times* to honor specialty pharmacies and their commitment to patients.

Mother-to-child transmission rates dropped to 1.9% in 2015.

HR 1038 would prohibit pharmacy benefit managers from charging direct and indirect remuneration fees.

Study finds more stringent data on efficacy should be collected in drug development.

Targeted therapy improves survival rates for dogs with hemangiosarcoma.

Antibody that binds to HIV and SIV leads to sustained remission.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

RA drug shows superiority compared with adalimumab and placebo.

Assay quantitates HCV viral load and confirms active HCV infection.

An in-depth look at the survey history and methodology.

Kaiser report finds the ACA played a significant role in the increase of health insurance for HIV-positive patients.

Community Oncology Alliance at odds with the opinion of pharmacy benefit managers regarding direct and indirect remuneration fees.

National Association of Specialty Pharmacy states that direct and indirect remuneration fees do harm the health industry and specialty pharmacy providers.

The World Health Organization seeks to improve early cancer detection to increase survivors and cut treatment costs.

Aggressive cancers found more susceptible to combination treatment compared with monotherapy.